This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirot, D.
Right arrow Articles by Sirot, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirot, D.
Right arrow Articles by Sirot, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 1998, p. 2184-2187, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Inhibitor-Resistant OXY-2-Derived beta -Lactamase Produced by Klebsiella oxytoca

D. Sirot,1,* R. Labia,2 P. Pouedras,3 C. Chanal-Claris,1 C. Cerceau,2 and J. Sirot1

Laboratoire de Bactériologie, Faculté de Médecine, 63001 Clermont-Ferrand Cedex,1 UMR 175, CNRS-MNHN, 29000 Quimper,2 and Centre Hospitalier, Vannes,3 France

Received 20 January 1998/Returned for modification 14 April 1998/Accepted 11 June 1998

Klebsiella oxytoca strains are generally moderately resistant to amoxicillin and ticarcillin due to the activities of the chromosomally encoded OXY-1 and OXY-2 class A beta -lactamase families. These enzymes have the ability to hydrolyze not only penicillins but also cephalosporins, including cefuroxime, ceftriaxone, and aztreonam, and are inhibited by clavulanic acid. A Klebsiella oxytoca strain was isolated from a culture of blood from a patient who had been treated with amoxicillin-clavulanate (3 g/day) for 10 days 1 month earlier. This strain harbored an unusual phenotype characterized by resistance to amoxicillin-clavulanate. It produced an OXY-2-type beta -lactamase (pI 6.3), as confirmed by PCR amplification with primers specific for the OXY-2-encoding gene. Gene sequencing revealed a point mutation (Aright-arrowG) corresponding to the amino acid substitution Serright-arrowGly at position 130. This mutant enzyme was poorly inhibited by inhibitors, and its kinetic constants compared to those of the parent enzyme were characterized by an increased Km value for ticarcillin, with a drastically reduced activity against cephalosporins, as is observed with inhibitor-resistant TEM enzymes. The substitution Serright-arrowGly-130 was previously described in the inhibitor-resistant beta -lactamase SHV-10 derived from an SHV-5 variant, but this is the first report of such a mutant in OXY enzymes from K. oxytoca.

* Corresponding author. Mailing address: Laboratoire de Bactériologie, Faculté de Médecine, 28 Place Henri-Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 4 73 60 80 18. Fax: 33 4 73 27 74 94. E-mail: Danielle.SIROT{at}u-clermont1.fr.

Antimicrobial Agents and Chemotherapy, September 1998, p. 2184-2187, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gonzalez-Lopez, J. J., Coelho, A., Larrosa, M. N., Lavilla, S., Bartolome, R., Prats, G. (2009). First Detection of Plasmid-Encoded blaOXY {beta}-Lactamase. Antimicrob. Agents Chemother. 53: 3143-3146 [Abstract] [Full Text]  
  • Mendonca, N., Manageiro, V., Robin, F., Salgado, M. J., Ferreira, E., Canica, M., Bonnet, R. (2008). The Lys234Arg Substitution in the Enzyme SHV-72 Is a Determinant for Resistance to Clavulanic Acid Inhibition. Antimicrob. Agents Chemother. 52: 1806-1811 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Nordmann, P. (2003). In Vivo Selection of a Chromosomally Encoded {beta}-Lactamase Variant Conferring Ceftazidime Resistance in Klebsiella oxytoca. Antimicrob. Agents Chemother. 47: 3739-3742 [Abstract] [Full Text]  
  • Granier, S. A., Leflon-Guibout, V., Goldstein, F. W., Nicolas-Chanoine, M.-H. (2003). New Klebsiella oxytoca {beta}-Lactamase Genes blaOXY-3 and blaOXY-4 and a Third Genetic Group of K. oxytoca Based on blaOXY-3. Antimicrob. Agents Chemother. 47: 2922-2928 [Abstract] [Full Text]  
  • Aumeran, C., Chanal, C., Labia, R., Sirot, D., Sirot, J., Bonnet, R. (2003). Effects of Ser130Gly and Asp240Lys Substitutions in Extended-Spectrum {beta}-Lactamase CTX-M-9. Antimicrob. Agents Chemother. 47: 2958-2961 [Abstract] [Full Text]  
  • Galan, J.-C., Morosini, M.-I., Baquero, M.-R., Reig, M., Baquero, F. (2003). Haemophilus influenzae blaROB-1 Mutations in Hypermutagenic {Delta}ampC Escherichia coli Conferring Resistance to Cefotaxime and {beta}-Lactamase Inhibitors and Increased Susceptibility to Cefaclor. Antimicrob. Agents Chemother. 47: 2551-2557 [Abstract] [Full Text]  
  • Granier, S. A., Plaisance, L., Leflon-Guibout, V., Lagier, E., Morand, S., Goldstein, F. W., Nicolas-Chanoine, M.-H. (2003). Recognition of two genetic groups in the Klebsiella oxytoca taxon on the basis of chromosomal {beta}-lactamase and housekeeping gene sequences as well as ERIC-1R PCR typing. Int. J. Syst. Evol. Microbiol. 53: 661-668 [Abstract] [Full Text]  
  • Miro, E., Navarro, F., Mirelis, B., Sabate, M., Rivera, A., Coll, P., Prats, G. (2002). Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant {beta}-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period. Antimicrob. Agents Chemother. 46: 3991-3994 [Abstract] [Full Text]  
  • Granier, S. A., Leflon-Guibout, V., Nicolas-Chanoine, M.-H., Bush, K., Goldstein, F. W. (2002). The Extended-Spectrum K1 {beta}-Lactamase from Klebsiella oxytoca SC 10,436 Is a Member of the blaOXY-2 Family of Chromosomal Klebsiella Enzymes. Antimicrob. Agents Chemother. 46: 2056-2057 [Full Text]  
  • Granier, S. A., Van, J.-C. N., Kitzis, M.-D., Goldstein, F. W., Leflon-Guibout, V., Nicolas-Chanoine, M.-H. (2002). First Description of a TEM-30 (IRT-2)-Producing Klebsiella oxytoca Isolate. Antimicrob. Agents Chemother. 46: 1158-1159 [Full Text]  
  • Sanders, C. C., Ehrhardt, A. F., Moland, E. S., Thomson, K. S., Zimmer, B., Roe, D. E. (2002). {beta}lasEN: Microdilution Panel for Identifying {beta}-Lactamases Present in Isolates of Enterobacteriaceae. J. Clin. Microbiol. 40: 123-127 [Abstract] [Full Text]  
  • Neuwirth, C., Madec, S., Siebor, E., Pechinot, A., Duez, J.-M., Pruneaux, M., Fouchereau-Peron, M., Kazmierczak, A., Labia, R. (2001). TEM-89 beta -Lactamase Produced by a Proteus mirabilis Clinical Isolate: New Complex Mutant (CMT 3) with Mutations in both TEM-59 (IRT-17) and TEM-3. Antimicrob. Agents Chemother. 45: 3591-3594 [Abstract] [Full Text]  
  • Fiett, J., Stankiewicz, M., Przondo-Mordarska, H., Hryniewicz, W., Gniadkowski, M. (2000). A Novel Complex Mutant beta -Lactamase, TEM-68, Identified in a Klebsiella pneumoniae Isolate from an Outbreak of Extended-Spectrum beta -Lactamase-Producing Klebsiellae. Antimicrob. Agents Chemother. 44: 1499-1505 [Abstract] [Full Text]  
  • Girlich, D., Karim, A., Poirel, L., Cavin, M.-H., Verny, C., Nordmann, P. (2000). Molecular epidemiology of an outbreak due to IRT-2 {beta}-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department. J Antimicrob Chemother 45: 467-473 [Abstract] [Full Text]  
  • Bermudes, H., Jude, F., Chaibi, E. B., Arpin, C., Bebear, C., Labia, R., Quentin, C. (1999). Molecular Characterization of TEM-59 (IRT-17), a Novel Inhibitor-Resistant TEM-Derived beta -Lactamase in a Clinical Isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 43: 1657-1661 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»